Monitor the outcome of the equity grant proposals (Proposals Three through Twenty-Three) and the RSU amendment (Proposal Sixteen) at the December 2, 2026 meeting. The large option and PSU grants to the CEO and President, if approved, will add to dilution over the vesting period; watch for any shareholder pushback on compensation levels given the company's early-stage profile.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+1- T+0 · Nov 9 $5.94entry
- T+1 · 11h ago −0.84%α −0.47% · $5.89
- T+5 · in 6d Pending
- T+20 · in 28d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Anteris Technologies Global Corp. filed its definitive proxy statement for the 2026 Annual Meeting scheduled for December 2, 2026. The meeting agenda includes the election of two Class II directors, ratification of KPMG as auditor, and a series of proposals seeking stockholder approval for equity grants to executive and non-executive directors, including RSUs, options, and performance-based PSUs, as well as amendments to outstanding RSU terms. The filing is largely routine governance and compensation matters, with no material financial or operational disclosures.
Key Facts
- Annual Meeting to be held December 2, 2026; record date October 29, 2026; 97,493,429 shares outstanding.
- Proposal One: Election of David St Denis and Stephen Denaro as Class II directors; both are incumbents, with St Denis serving as President and Denaro having rejoined the Board in May 2026.
- Proposal Two: Ratification of KPMG as independent auditor for fiscal year 2026.
- Proposals Three and Four: Approval of RSU grants to CEO Wayne Paterson (629,921 RSUs, $3,999,998) and President David St Denis (314,960 RSUs, $1,999,996) for 2025 service.
- Proposals Seven and Eight: Approval of 2026 option grants to Paterson (1,200,000 options, $6,747,655) and St Denis (414,000 options, $2,327,941).
- Proposals Seventeen and Eighteen: Approval of 2026 PSU grants to Paterson (800,000 PSUs, $3,864,800) and St Denis (485,000 PSUs, $2,343,035) with stock price hurdles of $20.50, $41.00, and $61.50.
- Proposal Sixteen: Approval of amendments to outstanding RSUs to allow cash settlement elections.
- CEO Wayne Paterson's 2025 total compensation was $6,131,101; President David St Denis's 2025 total compensation was $981,905.
- Medtronic plc holds a 16.1% stake (15,652,173 shares) and is subject to a standstill and voting agreement through May 22, 2027.
- No shareholder proposals were included in the proxy statement.
Financial Impact
Equity grants to executives and directors total approximately $20 million in grant date value, including $6.75M in options and $3.86M in PSUs to the CEO. These are non-cash compensation expenses.
Risk Factors
- Potential dilution from the approval of multiple large equity grants to executives and directors.
- Shareholder approval of equity grants is required under ASX Listing Rules; failure to pass could delay or cancel planned compensation.
- Medtronic's 16.1% stake and standstill/voting agreement could influence governance outcomes.
- The company is an emerging growth company with significant reliance on equity-based compensation, which may signal cash constraints.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEF 14A Filing (Primary) | 0001140361-26-042624 |
| Document: 0001140361-26-042624-index-headers.html | 0001140361-26-042624 |
| Document: 0001140361-26-042624-index.html | 0001140361-26-042624 |
| Document: 0001140361-26-042624.txt | 0001140361-26-042624 |
Track record
22 reports on AVR
4 of 9 bullish or bearish reports moved the stock their way by T+20. Best: +37.09% at T+60 after the Aug 11, 2026 report. 6 of 9 went positive at some point.
Filters
- Nov 10, 2026today Press Release Neutral 4/10 Entry $5.85 Now $5.89 +0.68% settles Dec 10
- Nov 9, 20261d ago DEF 14A Neutral 3/10 Viewing Entry $5.94 Now $5.89 −0.84% settles Dec 8
- Nov 9, 20261d ago 10-Q/A Neutral 2/10 Entry $5.94 Now $5.89 −0.84% settles Dec 8
- Nov 9, 20261d ago 10-Q/A Neutral 2/10 Entry $5.94 Now $5.89 −0.84% settles Dec 8
- Nov 9, 20261d ago 10-K/A Neutral 1/10 Entry $5.94 Now $5.89 −0.84% settles Dec 8
- Nov 5, 20265d ago SC 13G/A Neutral 2/10 Entry $5.58 Now $5.89 +5.56% settles Dec 4
- Nov 4, 20266d ago 3 Neutral 2/10 Entry $6.12 Now $5.89 −3.76% settles Dec 3
- Oct 6, 20265w ago Insider Buy Bullish 6/10 Entry $7.05 to $5.69 Now $5.89 −16.45% ▼ −19.29% −16.39% vs SPY
- Oct 1, 20265w ago Insider Buy Bullish 5/10 Entry $7.71 to $6.42 Now $5.89 −23.61% ▼ −16.73% −14.92% vs SPY
- Sep 23, 20266w ago 8-K Neutral 2/10 Entry $7.62 to $6.01 Now $5.89 −22.70% ▼ −21.13% −21.82% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers